Novartis AG (CHF)
NOVN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range81.13 | 82.65
52-Wk Range- | -
Last Close82.28
Mkt Cap (m)188,312.44
Dividend yield3.59
ISINCH0012005267
Volume5,037,581.00
Exchange VenueSWX

Company Profile

Novartis AG is a part of the healthcare industry. Its main activity is to research and develop healthcare products and pharmaceuticals such as oncology medicines, generic and biosimilar medicines and eye care devices.

Key Information
Price/Earning26.23
Price/Book3.81
Price/Sales3.91
P/CF14.22
Rev Growth (3 year avg)-0.51
EPS Growth (3 year avg)0.22
Operating Margin % 18.67
Net Margin %24.10
Return on Equity17.50
Debt/Equity0.53

Documents

Prospectus
en 12/02/2020
Annual Report
en 31/12/2019

Financials

Income Statement
CHF201420152016201720182019
Revenue (m)53,634.0050,387.0049,436.0050,135.0053,166.0048,677.00
Operating Income (m)11,089.008,977.008,268.008,629.008,169.009,086.00
Net Income (m)10,210.0017,783.006,712.007,703.0012,611.0011,732.00
Basic EPS4.217.402.823.285.445.12
Avg. Diluted Shares Outstanding (m)2,470.002,438.002,400.002,371.002,344.002,319.00
Balance Sheet
CHF201420152016201720182019
Current Assets (m)37,561.0022,845.0024,931.0028,208.0035,563.0029,504.00
Non Current Assets (m)87,826.00108,711.00105,193.00104,871.00110,000.0088,866.00
Total Assets (m)125,387.00131,556.00130,124.00133,079.00145,563.00118,370.00
Current Liabilities (m)26,973.0023,708.0022,209.0023,403.0029,607.0028,264.00
Total Liabilities (m)------
Total Equity (m)70,766.0077,046.0074,832.0074,168.0078,614.0055,474.00
Cash Flows
CHF201420152016201720182019
Operating Cash Flows (m)13,897.0011,897.0011,475.0012,621.0014,272.0013,625.00
Capital Expenditure (m)-3,404.00-3,505.00-2,879.00-2,746.00-3,355.00-2,257.00
Figures are quoted in CHF unless stated otherwise
-1.15 (-1.40%)
81.13
Last Price